138 related articles for article (PubMed ID: 21855181)
1. New fluorine-containing hydrazones active against MDR-tuberculosis.
Vavříková E; Polanc S; Kočevar M; Horváti K; Bosze S; Stolaříková J; Vávrová K; Vinšová J
Eur J Med Chem; 2011 Oct; 46(10):4937-45. PubMed ID: 21855181
[TBL] [Abstract][Full Text] [Related]
2. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antitubercular activity of ferrocene-based hydrazones.
Mahajan A; Kremer L; Louw S; Guérardel Y; Chibale K; Biot C
Bioorg Med Chem Lett; 2011 May; 21(10):2866-8. PubMed ID: 21507641
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides.
Sriram D; Yogeeswari P; Devakaram RV
Bioorg Med Chem; 2006 May; 14(9):3113-8. PubMed ID: 16412646
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
6. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
7. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
8. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
[TBL] [Abstract][Full Text] [Related]
9. Antitubercular activity of new coumarins.
Cardoso SH; Barreto MB; Lourenço MC; Henriques Md; Candéa AL; Kaiser CR; de Souza MV
Chem Biol Drug Des; 2011 Jun; 77(6):489-93. PubMed ID: 21414146
[TBL] [Abstract][Full Text] [Related]
10. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity.
Pavan FR; da S Maia PI; Leite SR; Deflon VM; Batista AA; Sato DN; Franzblau SG; Leite CQ
Eur J Med Chem; 2010 May; 45(5):1898-905. PubMed ID: 20163897
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitubercular activity of novel amino acid derivatives.
Da Costa CF; Pinheiro AC; De Almeida MV; Lourenço MC; De Souza MV
Chem Biol Drug Des; 2012 Feb; 79(2):216-22. PubMed ID: 22078007
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
[TBL] [Abstract][Full Text] [Related]
13. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
[TBL] [Abstract][Full Text] [Related]
14. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimycobacterial evaluation of pyrazinamide derivatives with benzylamino substitution.
Zitko J; Paterová P; Kubíček V; Mandíková J; Trejtnar F; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2013 Jan; 23(2):476-9. PubMed ID: 23237840
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives.
Turan-Zitouni G; Ozdemir A; Kaplancikli ZA; Benkli K; Chevallet P; Akalin G
Eur J Med Chem; 2008 May; 43(5):981-5. PubMed ID: 17719146
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evolution of hydrazones derived from 4-(trifluoromethyl)benzohydrazide.
Krátký M; Bősze S; Baranyai Z; Stolaříková J; Vinšová J
Bioorg Med Chem Lett; 2017 Dec; 27(23):5185-5189. PubMed ID: 29097168
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity.
Bedia KK; Elçin O; Seda U; Fatma K; Nathaly S; Sevim R; Dimoglo A
Eur J Med Chem; 2006 Nov; 41(11):1253-61. PubMed ID: 16919372
[TBL] [Abstract][Full Text] [Related]
19. Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.
Karunanidhi S; Chandrasekaran B; Karpoormath R; Patel HM; Kayamba F; Merugu SR; Kumar V; Dhawan S; Kushwaha B; Mahlalela MC
Bioorg Chem; 2021 Oct; 115():105133. PubMed ID: 34329993
[TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
